Background Routine use of whole‐cell pertussis (wP) vaccines was suspended in some
countries in the 1970s and 1980s because of concerns about adverse effects. Following this …

The combination of diphtheria, tetanus, and pertussis vaccines into a single product has
been central to the protection of the pediatric population over the past 50 years. The addition …

Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …

Background. Booster vaccination against tetanus and diphtheria at 10-year intervals is
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …

Replacement of cellular with acellular pertussis (aP) vaccines has considerably reduced the
systemic reactions observed with diphtheria-tetanus toxoids-pertussis vaccine but has not …

Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …

Objectives The aim of this study was to compare the immunogenicity and reactogenicity of a
lower dose diphtheria, tetanus and pertussis vaccine (dTpa) with the recommended vaccine …

OBJECTIVE. The aim of this study was to determine the site, extent, and resolution of tissue
involvement when extensive limb swelling occurred in the injected limb for children who …

Background: Immunization against diphtheria, tetanus and pertussis has been applied in
Iran since 1950. WHO suggests periodical evaluation of effectiveness of the triple diphtheria …

Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …